Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment.

MLA

Duncan, Andrew J., et al. “Decreased Ubiquinone Availability and Impaired Mitochondrial Cytochrome Oxidase Activity Associated with Statin Treatment.” Toxicology Mechanisms and Methods, vol. 19, no. 1, Jan. 2009, pp. 44–50. EBSCOhost, https://doi.org/10.1080/15376510802305047.

APA

Duncan, A. J., Hargreaves, I. P., Damian, M. S., Land, J. M., & Heales, S. J. R. (2009). Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment. Toxicology Mechanisms and Methods, 19(1), 44–50. https://doi.org/10.1080/15376510802305047

Chicago

Duncan, Andrew J, Iain P Hargreaves, Maxwell S Damian, John M Land, and Simon J R Heales. 2009. “Decreased Ubiquinone Availability and Impaired Mitochondrial Cytochrome Oxidase Activity Associated with Statin Treatment.” Toxicology Mechanisms and Methods 19 (1): 44–50. doi:10.1080/15376510802305047.